Physician profile
Frederick M Faust
NPI 1346350162
$595.10
in general payments reported to CMS, 2019-2025
18 companies · $20.36 in 2025
The $20.36 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.97 · 2020: $11.02 · 2022: $349 · 2023: $171 · 2024: $31.37 · 2025: $20.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $142.26 | 2022 | |
| Abbvie INC. | $83.88 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $48.62 | 2023-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Dexcom, INC. | $35.52 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $34.18 | 2022 | |
| Amgen INC. | $31.87 | 2022-2023 | Prolia, Evenity |
| Glaxosmithkline, LLC. | $30.52 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $28.69 | 2023 | Xtampza |
| Sanofi Pasteur INC. | $24.19 | 2022 | |
| Pfizer INC. | $20.36 | 2025 | |
| Nestle Healthcare Nutrition INC. | $19.66 | 2023 | |
| Abbott Laboratories | $15.83 | 2024 | Eterna |
| Takeda Pharmaceuticals U.S.A., INC. | $14.24 | 2022 | |
| Idorsia Pharmaceuticals US INC | $14.09 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.41 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.41 | 2023 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $13.35 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Faust listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.